Key result
Diabetes mellitus was independently associated with increased all-cause mortality at 30 days (P=0.0025) and 1 year (P<0.0001) following primary percutaneous coronary intervention for STEMI.
Why the study?
Does diabetes mellitus increase all-cause mortality in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction?
Cohort (n=2,586)
No
Does diabetes mellitus increase all-cause mortality in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction?
p-value: p=<0.0001
Diabetes mellitus remains independently associated with increased 30-day and 1-year all-cause mortality in patients undergoing contemporary primary PCI for STEMI.
No takes yet. Share an insight, caveat, or question.
Alerts clinicians to persistent mortality risk in diabetic STEMI patients after primary PCI; leaves open whether targeted strategies improve outcomes.
Kahn et al. (2011) conducted a cohort in ST-segment elevation myocardial infarction (STEMI) (n=2,586). Diabetes mellitus vs. No diabetes mellitus was evaluated on All-cause mortality at 30 days and 1 year (p=<0.0001). Diabetes mellitus was independently associated with increased all-cause mortality at 30 days (P=0.0025) and 1 year (P<0.0001) following primary percutaneous coronary intervention for STEMI.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: